Previous studies suggested that the GSTM1 null polymorphism has been linked with an increased risk of bladder cancer, especially among smokers (Engel et al., 2002; Garcia-Closas et al., 2005; Johns and Houlston, 2000; Salagovic et al., 1999). This evidence concerns the gene GSTM1 and urinary bladder cancer.